We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
-28.41%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$136M
AUM Growth
-$49.6M
Cap. Flow
+$12M
Cap. Flow %
8.84%
Top 10 Hldgs %
93.46%
Holding
20
New
3
Increased
–
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
ACB
Aurora Cannabis
ACB
+$13.3M
2
RVLP
RVL Pharmaceuticals plc Ordinary Shares
RVLP
+$1.8M
3
APHA
Aphria Inc. Common Shares
APHA
+$163K

Top Sells

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$2.58M
2
CRON
Cronos Group
CRON
+$289K
3
BBBY
Bed Bath & Beyond
BBBY
+$277K
4
SNOA icon
Sonoma Pharmaceuticals
SNOA
+$60K
5
TLGT
Teligent, Inc
TLGT
+$55K

Sector Composition

Rank Sector Weight
1 Healthcare 75.09%
2 Consumer Discretionary 21.72%
3 Technology 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGC
1
Canopy Growth
CGC
$377M
$34.7M 25.55%
129,120
– –
AMZN icon
2
Amazon
AMZN
$2.48T
$29.5M 21.72%
392,540
– –
EGRX
3
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$17.2M 12.64%
425,755
-50,000
-11% -$2.58M
CRON
4
Cronos Group
CRON
$1.06B
$11.2M 8.28%
1,081,444
-30,000
-3% -$289K
ACB
5
Aurora Cannabis
ACB
$168M
$10.7M 7.91%
+18,035
New +$13.3M
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.29M 3.9%
270,775
– –
ATRS
7
DELISTED
Antares Pharma, Inc.
ATRS
$5.22M 3.85%
1,920,524
– –
BSTC
8
DELISTED
BioSpecifics Technologies Corp.
BSTC
$4.46M 3.29%
73,649
– –
ESTA icon
9
Establishment Labs
ESTA
$2.7B
$4.39M 3.23%
160,000
– –
MSFT icon
10
Microsoft
MSFT
$2.92T
$4.21M 3.1%
41,500
– –
PETQ
11
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$3.49M 2.57%
148,855
– –
LGND icon
12
Ligand Pharmaceuticals
LGND
$5.94B
$1.82M 1.34%
21,482
– –
RVLP
13
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$1.74M 1.28%
+225,000
New +$1.8M
AVDL
14
DELISTED
Avadel Pharmaceuticals
AVDL
$1.15M 0.84%
444,439
– –
ALIM
15
DELISTED
Alimera Sciences
ALIM
$297K 0.22%
27,553
– –
NVLN
16
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$265K 0.2%
315,979
– –
APHA
17
DELISTED
Aphria Inc. Common Shares
APHA
$117K 0.09%
+20,636
New +$163K
BBBY
18
Bed Bath & Beyond
BBBY
$503M
– –
-13,310
Closed -$277K
SNOA icon
19
Sonoma Pharmaceuticals
SNOA
$5.46M
– –
-228
Closed -$60K
TLGT
20
DELISTED
Teligent, Inc
TLGT
– –
-1,382
Closed -$55K

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, JW Asset Management held 20 positions worth $136M, down 27% from $185M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

JW Asset Management deployed $12M of net new capital in Q4 2018, opening 3 new positions. Its largest new stake was Aurora Cannabis: 18,035 shares worth $10.7M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 76% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Eagle Pharmaceuticals, Inc., an estimated $2.58M trimmed.

  • JW Asset Management's largest Q4 2018 buy was Aurora Cannabis: 18,035 shares worth $10.7M.
  • JW Asset Management's biggest Q4 2018 reduction was Eagle Pharmaceuticals, Inc., cutting an estimated $2.58M.
  • JW Asset Management fully exited Bed Bath & Beyond in Q4 2018, selling an estimated $277K.
  • JW Asset Management's ten largest holdings make up 93% of its $136M portfolio in Q4 2018.
  • JW Asset Management opened 3 new positions and closed 3 in Q4 2018.
  • JW Asset Management's portfolio value fell 27% quarter-over-quarter to $136M.

Based on JW Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.